Ikarian Capital, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value (AVTX)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol
AVTX
Shares outstanding
11,931,502 shares
Disclosed Ownership
1,191,957 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 17:33:21 UTC
Date of event
31 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 10% 1,191,957 0 1,191,957 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 10% 1,191,957 0 1,191,957 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager